Postoperative Adjuvant Anastrozole for 10 Rather than 5 Years in Patients with Oestrogen Receptor-Positive Breast Cancer: AERAS, a Randomised Multicentre Open-Label Phase III Trial

A phase III trial to determine the activity and safety of fulvestrant (Faslodex®) in premenopausal women with oestrogen-receptor positive breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80305-7 ◽

2002 ◽

Vol 38 (11) ◽

pp. S97 ◽

Cited By ~ 1

Author(s):

J Robertson

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Premenopausal Women ◽

Phase Iii ◽

Phase Iii Trial ◽

Positive Breast Cancer

Download Full-text

Abstract OT-01-02: Adaptlate -a randomized, controlled, open-label, phase-iii trial on adjuvant dynamic marker - adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, hr+/her2- early breast cancer

10.1158/1538-7445.sabcs20-ot-01-02 ◽

2021 ◽

Author(s):

Oleg Gluz ◽

Tom Degenhardt ◽

Norbert Marschner ◽

Matthias Christgen ◽

Hans Heinrich Kreipe ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Adjuvant Endocrine Therapy ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Open Label Phase

Download Full-text

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy097 ◽

2018 ◽

Vol 48 (9) ◽

pp. 855-859 ◽

Cited By ~ 2

Author(s):

Yutaka Yamamoto ◽

Hiroji Iwata ◽

Takayuki Ueno ◽

Naruto Taira ◽

Masahiro Kashiwaba ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase Iii ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase ◽

Previously Treated

Download Full-text

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

10.1158/0008-5472.sabcs10-s4-1 ◽

2010 ◽

Cited By ~ 5

Author(s):

H Joensuu ◽

P-L Kellokumpu-Lehtinen ◽

R Huovinen ◽

A Jukkola-Vuorinen ◽

M Tanner ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Early Breast Cancer ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase

Download Full-text

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

Annals of Oncology ◽

10.1093/annonc/mdy272.357 ◽

2018 ◽

Vol 29 ◽

pp. viii121 ◽

Cited By ~ 1

Author(s):

S. Loibl ◽

O. Metzger ◽

S.J. Mandrekar ◽

C. Mundhenke ◽

S. Seiler ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Induction Treatment ◽

Efficacy And Safety ◽

Her2 Positive ◽

Open Label ◽

Phase Iii Trial ◽

Hormone Receptor Positive ◽

Open Label Phase

Download Full-text

179TiP EMERALD: A randomized, open-label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901), a novel oral selective estrogen receptor degrader (SERD), vs investigator’s choice of endocrine therapy for ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy

Annals of Oncology ◽

10.1016/j.annonc.2020.03.279 ◽

2020 ◽

Vol 31 ◽

pp. S80

Author(s):

A. Bardia ◽

J. Lu ◽

V. Kaklamani ◽

J. Jung ◽

A.T. Anderson-Villaluz ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Endocrine Therapy ◽

Inhibitor Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase

Download Full-text

PROCAPP: A randomized, open-label phase III trial comparing mapisal and urea hand-foot cream as prophylaxis for capecitabine-induced hand-foot skin reaction (HFSR) in patients (pts) with gastrointestinal (GI) tumors or breast cancer—A study of the AIO Quality of Life Working Group.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.9631 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 9631-9631 ◽

Cited By ~ 1

Author(s):

Deniz Gencer ◽

Andreas Schneeweiss ◽

Holger Schulz ◽

Michael Stahl ◽

Susanna Hegewisch-Becker ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Skin Reaction ◽

Working Group ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase ◽

Hand Foot Skin Reaction

Download Full-text

A randomised two-arm, prospective, multi-centre, open-label phase III trial comparing the activity and safety of a weekly versus a three-weekly paclitaxel treatment schedule in patients with advanced or metastatic breast cancer

http://isrctn.org/> ◽

10.1186/isrctn52817670 ◽

2012 ◽

Author(s):

M Verrill

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Weekly Paclitaxel ◽

Treatment Schedule ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase ◽

Paclitaxel Treatment

Download Full-text

Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2015.03.018 ◽

2015 ◽

Vol 51 (12) ◽

pp. 1481-1489 ◽

Cited By ~ 21

Author(s):

Amir Sonnenblick ◽

Prudence A. Francis ◽

Hatem A. Azim ◽

Evandro de Azambuja ◽

Bo Nordenskjöld ◽

...

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Phase Iii ◽

Phase Iii Trial ◽

Breast International Group ◽

International Group ◽

Group 2 ◽

Positive Breast Cancer

Download Full-text

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

Cancer Research and Treatment ◽

10.4143/crt.2017.562 ◽

2019 ◽

Vol 51 (1) ◽

pp. 43-52 ◽

Cited By ~ 7

Author(s):

In Hae Park ◽

Seock-Ah Im ◽

Kyung Hae Jung ◽

Joo Hyuk Sohn ◽

Yeon Hee Park ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase ◽

Previously Treated

Download Full-text